Charles Herbaux

The MLL recombinome of acute leukemias in 2013

Claus Meyer, Jörg Hofmann, Thomas Burmeister et al. · Leukemia · 2013 · 507 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

Meletios Α. Dimopoulos, Alessandra Tedeschi, Judith Trotman et al. · New England Journal of Medicine · 2018 · 350 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib

David Ghez, Anne Calleja, Caroline Protin et al. · Blood · 2018 · 296 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

Nicolas Delanoy, Jean‐Marie Michot, Thibault Comont et al. · The Lancet Haematology · 2018 · 292 citations

Pharmacy, Hematology, Immunology +16

MYD88 L265P mutation in Waldenstrom macroglobulinemia

Stéphanie Poulain, Christophe Roumier, Audrey Decambron et al. · Blood · 2013 · 231 citations · Full text

Life Sciences, Genetics, Molecular Genetics +6